SENP1-knockdown effectively suppressed HBx-induced OCT4/EMT expression and inhibited intrahepatic and pulmonary metastases in vivo, suggesting that SENP1 could serve as a prognostic marker and a potential therapeutic target in HBV-related HCC. Here, SENP1 is linked to hepatocellular carcinoma.